KBC Group NV - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$1980.0%200,0000.0%0.00%0.0%
Q2 2023$198
-3.9%
200,0000.0%0.00%0.0%
Q1 2023$206
+3.5%
200,0000.0%0.00%0.0%
Q4 2022$199
-99.9%
200,0000.0%0.00%0.0%
Q3 2022$199,000
+0.5%
200,0000.0%0.00%0.0%
Q2 2022$198,000
-99.5%
200,000
-50.0%
0.00%
-99.3%
Q1 2022$40,316,000
+91.4%
400,000
+100.0%
0.15%
+125.8%
Q4 2021$21,062,000
+20348.5%
200,000
+100.0%
0.07%
Q3 2021$103,000
-50.5%
100,000
-50.0%
0.00%
Q2 2021$208,000
-49.3%
200,000
-50.0%
0.00%
-100.0%
Q1 2021$410,000
-4.7%
400,0000.0%0.00%
Q4 2020$430,000
+105.7%
400,000
+100.0%
0.00%
-100.0%
Q3 2020$209,000
-57.5%
200,000
-50.0%
0.00%
-50.0%
Q2 2020$492,000
+16.0%
400,0000.0%0.00%
-33.3%
Q4 2019$424,000400,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 19,413,000$19,245,6111.50%
SSI INVESTMENT MANAGEMENT LLC 9,386,000$9,219,5660.65%
PFM Health Sciences, LP 15,000,000$14,771,5200.57%
RWC Asset Management LLP 11,000,000$10,848,4750.52%
Sonora Investment Management Group, LLC 6,280,000$6,184,8580.52%
ADVENT CAPITAL MANAGEMENT /DE/ 24,020,000$23,654,1280.46%
Lombard Odier Asset Management (Europe) Ltd 7,224,000$7,124,4890.34%
MACKAY SHIELDS LLC 10,123,000$9,943,5200.28%
PALISADE CAPITAL MANAGEMENT, LP 9,478,000$9,323,9830.25%
Nicholas Investment Partners, LP 2,940,000$2,887,8680.20%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders